The company manufactures and exports metal packaging solutions, specifically tin cans and printed metal sheets, primarily for the food and fast-moving consumer goods industries.
The company operates in a commodity-like industry with low margins and high competition from plastic alternatives, and while it has long-standing customer relationships, the low ROCE of 10% suggests no significant cost or scale advantage.
Management is currently reinvesting in a new manufacturing unit in Haryana to drive growth, but historical returns on equity are low at 7.2%, and dividend payouts are modest relative to the capital needs of the business.
The capital-intensive expansion in Haryana failed to generate returns above the cost of capital, further diluting an already weak ROE. As plastic and sustainable packaging alternatives accelerated their market share gains, the company's lack of pricing power led to margin compression that turned the 2.1 interest coverage into a liquidity crisis. The unresolved litigation and unconfirmed balances eventually manifested as significant write-downs, while promoter-linked transactions drained remaining cash, leaving minority shareholders with a hollowed-out commodity business that could no longer service its debt.
RichFakir rates Hindustan Tin Works Ltd's business quality as poor — 40/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Hindustan Tin Works Ltd is trading about 20% below our estimate of fair value; we rate its price fair. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Hindustan Tin Works Ltd is: Not rated. A poor business at a fair price — it does not make our shortlist right now. We marked it down a notch: revenue and earnings barely grow — a steady cash cow, not a compounder.
RichFakir's educational estimate of Hindustan Tin Works Ltd's fair value is about ₹136 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →